Humulin 70/30 and Symbicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humulin 70/30 and Symbicort. Common interactions include blood alkaline phosphatase increased among females and cerebral small vessel ischaemic disease among males.

The phase IV clinical study analyzes what interactions people who take Humulin 70/30 and Symbicort have. It is created by eHealthMe based on reports of 10 people who take Humulin 70/30 and Symbicort from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

10 people who take Humulin 70/30 and Symbicort together, and have interactions are studied.


What is Humulin 70/30?

Humulin 70/30 has active ingredients of insulin recombinant human; insulin susp isophane recombinant human. It is often used in diabetes. eHealthMe is studying from 4,697 Humulin 70/30 users for its effectiveness, alternative drugs and more.

What is Symbicort?

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 90,520 Symbicort users for its effectiveness, alternative drugs and more.

Number of Humulin 70/30 and Symbicort reports submitted per year:

Humulin 70/30 and Symbicort drug interactions.

Common Humulin 70/30 and Symbicort drug interactions by gender *:

female:

  1. Blood alkaline phosphatase increased
  2. Breast cancer
  3. Coronary artery occlusion
  4. Diabetes mellitus inadequate control
  5. Disease progression
  6. Dysphonia
  7. Dyspnoea
  8. Fall
  9. Hunger
  10. Hypertension

male:

  1. Cerebral small vessel ischaemic disease
  2. Cerebrovascular accident

Common Humulin 70/30 and Symbicort drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood glucose increased
  2. Chest discomfort
  3. Drug ineffective
  4. Hypersensitivity
  5. Hypoglycaemia
  6. Injection site swelling
  7. Urticaria
  8. Wheezing
  9. Cerebral small vessel ischaemic disease
  10. Cerebrovascular accident

60+:

  1. Blood alkaline phosphatase increased
  2. Diabetes mellitus inadequate control
  3. Disease progression
  4. Dysphonia
  5. Dyspnoea
  6. Hypoaesthesia oral
  7. Irritability
  8. Paraesthesia
  9. Pruritus
  10. Visual impairment

Common conditions people have *:

  1. Breast Cancer Female: 2 people, 20.00%
  2. Type 2 Diabetes: 1 person, 10.00%
  3. Testicular Failure (testicles cannot produce sperm or male hormones): 1 person, 10.00%
  4. Insomnia (sleeplessness): 1 person, 10.00%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 10.00%
  6. High Blood Pressure: 1 person, 10.00%
  7. Breast Cancer: 1 person, 10.00%
  8. Blood Glucose Increased: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Humulin 70/30 and Symbicort?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Humulin 70/30 and Symbicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Humulin 70/30 interactions:

Browse all interactions between Humulin 70/30 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Symbicort interactions:

Browse all interactions between Symbicort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant human; insulin susp isophane recombinant human and budesonide; formoterol fumarate dihydrate (the active ingredients of Humulin 70/30 and Symbicort, respectively), and Humulin 70/30 and Symbicort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: